[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100541724":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":22,"locations":27,"responsibleParty":40,"collaborators":10,"id":42,"slug":10,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"European Institute of Oncology","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"image-guided thermal ablation",null,"image-guided thermal ablation in patients with diagnosis of micropapillary thyroid carcinoma",[13],"Procedure: image-guided thermal ablation",[15],{"type":16,"name":9,"description":11,"armGroupLabels":17,"otherNames":10},"PROCEDURE",[9],[19],{"name":20,"affiliation":5,"role":21},"Giovanni Mauri","PRINCIPAL_INVESTIGATOR",[23],{"name":20,"role":24,"phone":25,"phoneExt":10,"email":26},"CONTACT","+390294372691","giovanni.mauri@ieo.it",[28],{"facility":5,"status":29,"city":30,"state":10,"zip":10,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Milan","Italy",{"type":33,"coordinates":34},"Point",[35,36],9.18951,45.46427,{"lat":36,"lon":35},[39],{"name":20,"role":24,"phone":10,"phoneExt":10,"email":10},{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100541724",false,"NCT06333587","Minimally Invasive Treatments of the Thyroid","Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma","MIPA-MITT","Inclusion Criteria:\n\n* Patients \\> 18years\n* Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT.\n* Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.\n* Patients must be accessible for follow-up\n\nExclusion Criteria:\n\n* Tumors \\> 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders\n* Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study","ALL","18 Years",{"count":52,"type":53},270,"ESTIMATED","OBSERVATIONAL","This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)",[57],"Papillary Thyroid Microcarcinoma","2024-03-21",{"date":60,"type":61},"2024-03-27","ACTUAL",{"date":63,"type":61},"2022-10-10",{"date":65,"type":53},"2035-12-31",{"name":5,"class":6},1]